Biopharmas raising money in public or private financings, including: 4D Molecular, Beyondspring, Briacell, Elevation, Emergex, Evommune, Five Prime, Gan & Lee, Hemogenyx, Keros, Kodiak, Oblique, Oncternal, Oric, Pharvaris, Population Health Investment, Qiming, Scopus, Umoja, Xiaomi.